Ideagen logo

IDEA - Ideagen News Story

148.25p 0.8  0.5%

Last Trade - 4:23pm

Sector
Technology
Size
Small Cap
Market Cap £326.5m
Enterprise Value £327.8m
Revenue £46.7m
Position in Universe 667th / 1816

Ideagen PLC - Exercise of Options and Issue of Shares

Tue 27th August, 2019 2:21pm
RNS Number : 2989K
Ideagen PLC
27 August 2019
 

Ideagen PLC

("Ideagen," "the Company" or the "Group'')

Exercise of Options, Issues of Shares and Total Voting Rights

Ideagen PLC (AIM: IDEA), a leading supplier of Information Management Software to highly regulated industries, announces that it has allotted a total of 10,000 new ordinary shares of 1 penny each in the capital of the Company ("Ordinary Shares") following the exercise of 10,000 options by employees.

Application has been made to the London Stock Exchange for the 10,000 new Ordinary Shares to be admitted to trading on AIM ("Admission") and it is expected that Admission will become effective and trading will commence at 8.00 a.m. on 2 September 2019.

On Admission, the total number of Ordinary Shares in issue will be 219,814,235 and the total number of voting rights will therefore be 219,814,235. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the FCA's Disclosure and Transparency Rules.

Enquiries:

Ideagen plc

01629 699100

David Hornsby, Executive Chairman

 

Ben Dorks, Chief Executive

 

Graeme Spenceley, Finance Director

 

 

 

finnCap Limited

020 7220 0500

Henrik Persson/James Thompson (Nomad)

 

Alice Lane (ECM)

 

 

Canaccord Genuity

 

020 7523 8000

Simon Bridges

 

Richard Andrews

 

 

About Ideagen plc

 

Ideagen is a UK-headquartered, global technology company quoted on the London Stock Exchange AIM market (Ticker: IDEA.L).

The Group provides IRM software and services to organisations operating within highly regulated industries such as aviation, banking and finance and life science, with its main operational premises spread throughout the UK, EU, US, Middle East and SE Asia.

With an excellent portfolio of software products including Q-Pulse, Coruson, Pentana Audit and PleaseReview, Ideagen helps its clients reduce costs, improve operational efficiency, strengthen compliance and oversight and anticipate and manage every detail of risk.

Currently, more than 4,700 organisations use Ideagen's products including seven of the top 10 UK accounting firms, all of the top aerospace and defence companies and 75% of the world's leading pharmaceutical firms.

Ideagen's diverse and varied customer base includes many well-known, global brands such as British Airways, Aggreko, BAE, Ryanair, US Navy, KLM, BBVA, Bank of New York, Commerzbank, Meggitt, Heineken, Johnson Matthey, Haeco Group and European Central Bank. As well as this, Ideagen counts 180 hospitals across the UK and US amongst its client base.

For further information please visit www.ideagen.com

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
IOEPRMJTMBBTBFL
© Stockopedia 2019, Thomson Reuters, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.